, a fintech survivor, sees price target at Wells Fargo increased to $575 per share from $550. The analysts see nice long-term forecast at recent Analyst Day. Keep overweight rating. to peer perform from outperform . Wolfe's survey of sleep doctors shows risk from the new class of weight-loss drugs.
Interesting because the maker of CPAP machines has had a nice run. price target to $48 per share from $40. Keeps buy. Provider of services and products to oil and chemical companies as well as other industrial-focused firms. gets price target bump to $38 per share from $36 at BofA. Keeps buy rating. Like the old days, rails have been very weak.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: CNBC - 🏆 12. / 72 Read more »
Source: CNBC - 🏆 12. / 72 Read more »
Source: NBCPhiladelphia - 🏆 569. / 51 Read more »
Source: NBCLA - 🏆 319. / 59 Read more »